panitumumab
amgen,takeda
['#gi', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm', 'improve ']
dr presents the study schema for his improve trial looking at intermittent vs continuous folfiri + pan for unresectable ras/braf wt metastatic #crcsm #gionc #asco22 
#FosterCare alum, #GIonc, #pallonc, and #survonc doc @ParkviewHealth.Uniting support and cancer care #supponc #hpm #hapc  Tweets are own.